Dova Pharmaceuticals

NC · United States · Reporting entity ID 100000316818

Total reported 2019–2025

$4.89M

#714 of 2,960 reporting companies — 0% of all reported industry payments

$2.75M in general payments across 9,672 records, plus $2.14M in research funding across 337 records.

How it breaks down

General payments $2,754,543

Research funding $2,136,592

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.